Published in Int J Obes Relat Metab Disord on December 01, 2003
Physical activity and weight gain prevention. JAMA (2010) 5.27
Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans. Am J Clin Nutr (2011) 4.60
Ten putative contributors to the obesity epidemic. Crit Rev Food Sci Nutr (2009) 2.71
Energy balance and its components: implications for body weight regulation. Am J Clin Nutr (2012) 2.51
Validation study of energy expenditure and intake during calorie restriction using doubly labeled water and changes in body composition. Am J Clin Nutr (2007) 2.33
Effect of calorie restriction with or without exercise on body composition and fat distribution. J Clin Endocrinol Metab (2007) 2.33
Molecular physiology of weight regulation in mice and humans. Int J Obes (Lond) (2008) 1.49
Energy metabolism, fuel selection and body weight regulation. Int J Obes (Lond) (2008) 1.39
Energy expenditure and adiposity in Nigerian and African-American women. Obesity (Silver Spring) (2008) 1.24
Energy expenditure does not predict weight change in either Nigerian or African American women. Am J Clin Nutr (2008) 1.24
Fat: an evolving issue. Dis Model Mech (2012) 1.15
Using the energy gap to address obesity: a commentary. J Am Diet Assoc (2009) 1.12
Elevated objectively measured but not self-reported energy intake predicts future weight gain in adolescents. Appetite (2014) 1.04
Energy expenditure in adults living in developing compared with industrialized countries: a meta-analysis of doubly labeled water studies. Am J Clin Nutr (2010) 1.04
Examination of cognitive function during six months of calorie restriction: results of a randomized controlled trial. Rejuvenation Res (2007) 0.94
Physical activity and modernization among Bolivian Amerindians. PLoS One (2013) 0.91
Estimation of activity related energy expenditure and resting metabolic rate in freely moving mice from indirect calorimetry data. PLoS One (2012) 0.90
Resting energy expenditure changes with weight loss: racial differences. Obesity (Silver Spring) (2009) 0.88
Epidemiological study designs to investigate gene-behavior interactions in the context of human obesity. Obesity (Silver Spring) (2008) 0.85
Individual differences in physical activity are closely associated with changes in body weight in adult female rhesus monkeys (Macaca mulatta). Am J Physiol Regul Integr Comp Physiol (2006) 0.85
Genes and biochemical pathways in human skeletal muscle affecting resting energy expenditure and fuel partitioning. J Appl Physiol (1985) (2010) 0.84
Associations among calcium intake, resting energy expenditure, and body fat in a multiethnic sample of children. J Pediatr (2010) 0.81
Integrating muscle cell biochemistry and whole-body physiology in humans:(31)P-MRS data from the InSight trial. Sci Rep (2013) 0.80
Pregnancy as a window to future health: Excessive gestational weight gain and obesity. Semin Perinatol (2015) 0.79
An objective estimate of energy intake during weight gain using the intake-balance method. Am J Clin Nutr (2014) 0.79
Smaller size of high metabolic rate organs explains lower resting energy expenditure in Asian-Indian Than Chinese men. Int J Obes (Lond) (2015) 0.77
From the past to future: from energy expenditure to energy intake to energy expenditure. Eur J Clin Nutr (2016) 0.77
Examination of mechanisms (E-MECHANIC) of exercise-induced weight compensation: study protocol for a randomized controlled trial. Trials (2014) 0.76
Choroidal thickness in obese women. BMC Ophthalmol (2016) 0.75
Does basal metabolic rate predict weight gain? Am J Clin Nutr (2016) 0.75
Accelerometer-measured physical activity is not associated with two-year weight change in African-origin adults from five diverse populations. PeerJ (2017) 0.75
A Genome-Wide Association Study Using a Custom Genotyping Array Identifies Variants in GPR158 Associated with Reduced Energy Expenditure in American Indians. Diabetes (2017) 0.75
Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med (1995) 8.51
Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet (2000) 8.33
The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest (1999) 7.35
Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med (1993) 6.89
Changing habits to delay diabetes. N Engl J Med (2001) 5.30
Determinants of 24-hour energy expenditure in man. Methods and results using a respiratory chamber. J Clin Invest (1986) 5.18
Circulating ghrelin levels are decreased in human obesity. Diabetes (2001) 4.28
Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes (1997) 4.17
Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. Am J Epidemiol (2000) 3.87
Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia (2000) 3.63
Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. N Engl J Med (1988) 3.41
Energy expenditure by doubly labeled water: validation in humans and proposed calculation. Am J Physiol (1986) 3.35
Reduced rate of energy expenditure as a risk factor for body-weight gain. N Engl J Med (1988) 3.19
Low ratio of fat to carbohydrate oxidation as predictor of weight gain: study of 24-h RQ. Am J Physiol (1990) 3.01
Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. J Clin Invest (1987) 2.96
Vascular risk factors, incidence of MCI, and rates of progression to dementia. Neurology (2004) 2.81
Obesity and insulin resistance: lessons learned from the Pima Indians. Diabetes Metab Rev (1988) 2.64
Skeletal muscle metabolism is a major determinant of resting energy expenditure. J Clin Invest (1990) 2.63
Correlation between muscle glycogen synthase activity and in vivo insulin action in man. J Clin Invest (1984) 2.62
Neuroanatomical correlates of hunger and satiation in humans using positron emission tomography. Proc Natl Acad Sci U S A (1999) 2.55
Body mass index as a measure of adiposity in children and adolescents: relationship to adiposity by dual energy x-ray absorptiometry and to cardiovascular risk factors. J Clin Endocrinol Metab (2001) 2.52
Is a low leptin concentration, a low resting metabolic rate, or both the expression of the "thrifty genotype"? Results from Mexican Pima Indians. Am J Clin Nutr (1998) 2.42
Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus. Int J Obes Relat Metab Disord (2004) 2.40
Twenty-four-hour energy expenditure and resting metabolic rate in obese, moderately obese, and control subjects. Am J Clin Nutr (1982) 2.37
Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development. Diabetes Care (2001) 2.33
Effect of satiation on brain activity in obese and lean women. Obes Res (2001) 2.25
An autosomal genomic scan for loci linked to prediabetic phenotypes in Pima Indians. J Clin Invest (1998) 2.18
Microarray profiling of skeletal muscle tissues from equally obese, non-diabetic insulin-sensitive and insulin-resistant Pima Indians. Diabetologia (2002) 2.08
Energy metabolism in African Americans: potential risk factors for obesity. Am J Clin Nutr (1999) 2.03
Microarray profiling of isolated abdominal subcutaneous adipocytes from obese vs non-obese Pima Indians: increased expression of inflammation-related genes. Diabetologia (2005) 2.03
Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects. J Clin Invest (1984) 2.03
Use of dual-energy X-ray absorptiometry in obese individuals. Am J Clin Nutr (1995) 2.02
Insulin resistance associated with lower rates of weight gain in Pima Indians. J Clin Invest (1991) 2.02
Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic-receptor gene. N Engl J Med (1995) 1.99
Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance. Diabetes (1999) 1.98
Relationship of genetics, age, and physical fitness to daily energy expenditure and fuel utilization. Am J Clin Nutr (1989) 1.96
Familial dependence of the resting metabolic rate. N Engl J Med (1986) 1.94
Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes Res (2001) 1.89
Relationship between degree of obesity and in vivo insulin action in man. Am J Physiol (1985) 1.89
Effects of glucocorticoids on energy metabolism and food intake in humans. Am J Physiol (1996) 1.86
Higher sedentary energy expenditure in patients with Huntington's disease. Ann Neurol (2000) 1.86
A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance. J Clin Invest (2000) 1.85
Differential brain responses to satiation in obese and lean men. Diabetes (2000) 1.81
Autosomal genomic scan for loci linked to obesity and energy metabolism in Pima Indians. Am J Hum Genet (1998) 1.78
Obesity in the Pima Indians: its magnitude and relationship with diabetes. Am J Clin Nutr (1991) 1.77
A high fasting plasma insulin concentration predicts type 2 diabetes independent of insulin resistance: evidence for a pathogenic role of relative hyperinsulinemia. Diabetes (2000) 1.73
A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM. Diabetologia (1995) 1.70
In vivo insulin action is familial characteristic in nondiabetic Pima Indians. Diabetes (1987) 1.70
Racial differences in the relation between blood pressure and insulin resistance. N Engl J Med (1991) 1.68
Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects. J Clin Endocrinol Metab (2004) 1.63
Energy intake and physical activity in Pima Indians: comparison with energy expenditure measured by doubly-labeled water. Obes Res (1994) 1.58
Daily energy expenditure in Mexican and USA Pima indians: low physical activity as a possible cause of obesity. Int J Obes Relat Metab Disord (2000) 1.55
Low urinary chiro-inositol excretion in non-insulin-dependent diabetes mellitus. N Engl J Med (1990) 1.54
A comparative study of different means of assessing long-term energy expenditure in humans. Am J Physiol (1996) 1.52
An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J Clin Invest (1995) 1.51
Determinants of energy expenditure and fuel utilization in man: effects of body composition, age, sex, ethnicity and glucose tolerance in 916 subjects. Int J Obes Relat Metab Disord (1999) 1.51
Energy metabolism after 2 y of energy restriction: the biosphere 2 experiment. Am J Clin Nutr (2000) 1.50
Energy expenditure, fat oxidation, and body weight regulation: a study of metabolic adaptation to long-term weight change. J Clin Endocrinol Metab (2000) 1.49
Analysis of MGEA5 on 10q24.1-q24.3 encoding the beta-O-linked N-acetylglucosaminidase as a candidate gene for type 2 diabetes mellitus in Pima Indians. Mol Genet Metab (2002) 1.48
Energy cost of physical activity on a metabolic ward in relationship to obesity. Am J Clin Nutr (1991) 1.48
Increased expression of inflammation-related genes in cultured preadipocytes/stromal vascular cells from obese compared with non-obese Pima Indians. Diabetologia (2005) 1.47
Relationship between insulin-mediated glucose disposal and lipid metabolism in man. J Clin Invest (1985) 1.44
Adiponectin receptors gene expression and insulin sensitivity in non-diabetic Mexican Americans with or without a family history of Type 2 diabetes. Diabetologia (2004) 1.43
Energy expenditure before and during energy restriction in obese patients. Am J Clin Nutr (1985) 1.42
Cloning and characterization of PDK4 on 7q21.3 encoding a fourth pyruvate dehydrogenase kinase isoenzyme in human. J Biol Chem (1996) 1.41
Skeletal muscle membrane lipid composition is related to adiposity and insulin action. J Clin Invest (1995) 1.41
Association between uncoupling protein polymorphisms (UCP2-UCP3) and energy metabolism/obesity in Pima indians. Hum Mol Genet (1998) 1.40
Energy metabolism, fuel selection and body weight regulation. Int J Obes (Lond) (2008) 1.39
Decreased expression of apM1 in omental and subcutaneous adipose tissue of humans with type 2 diabetes. Int J Exp Diabetes Res (2000) 1.36
Effect of muscle glycogen depletion on in vivo insulin action in man. J Clin Invest (1983) 1.35
Glucose storage is a major determinant of in vivo "insulin resistance" in subjects with normal glucose tolerance. J Clin Endocrinol Metab (1986) 1.32
Subcutaneous abdominal adipocyte size, a predictor of type 2 diabetes, is linked to chromosome 1q21--q23 and is associated with a common polymorphism in LMNA in Pima Indians. Mol Genet Metab (2001) 1.32
Relationship between obesity and maximal insulin-stimulated glucose uptake in vivo and in vitro in Pima Indians. J Clin Invest (1984) 1.32
Exaggerated early insulin release and insulin resistance in a diabetes-prone population: a metabolic comparison of Pima Indians and Caucasians. J Clin Endocrinol Metab (1991) 1.30
Determinants of total daily energy expenditure: variability in physical activity. Am J Clin Nutr (1994) 1.29
Insulin downregulates pyruvate dehydrogenase kinase (PDK) mRNA: potential mechanism contributing to increased lipid oxidation in insulin-resistant subjects. Mol Genet Metab (1998) 1.27
Abnormal regulation of protein tyrosine phosphatase activities in skeletal muscle of insulin-resistant humans. Diabetes (1991) 1.27
Fasting hyperinsulinemia is a predictor of increased body weight gain and obesity in Pima Indian children. Diabetes (1997) 1.26
Increase in insulin action and fat oxidation after treatment with CL 316,243, a highly selective beta3-adrenoceptor agonist in humans. Diabetes (1998) 1.26